Anixa Biosciences Share Price (NASDAQ: ANIX)

▲

-0.01

(-0.33%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Anixa Biosciences Stock chart to analyse performance

Anixa Biosciences stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$2.99
Today's High:$3.01
$3.00
0.33%
Downside
Day's Volatility :0.66%
Upside
0.33%
52 Weeks Low:$2.07
52 Weeks High:$4.20
$3.00
31.0%
Downside
52 Weeks Volatility :50.71%
Upside
28.57%

Anixa Biosciences Stock Returns

Period	Anixa Biosciences, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	3.46%	3.6%	0.0%
6 Months	5.28%	-7.7%	0.0%
1 Year	-7.43%	-12.6%	0.0%
3 Years	-30.47%	10.2%	-4.1%

Anixa Biosciences, Inc. Key Stats

Check Anixa Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.01
Open	$3.0
Today's High	$3.01
Today's Low	$2.99
Market Capitalization	$96.3M
Today's Volume	$19.5K
52 Week High	$4.2
52 Week Low	$2.07
Revenue TTM	$0.0
EBITDA	$-13.1M
Earnings Per Share (EPS)	$-0.38
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-65.38%

Stock Returns calculator for Anixa Biosciences Stock including INR - Dollar returns

The Anixa Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Anixa Biosciences investment value today

Current value as on today

₹98,163

Returns

₹1,837

(-1.84%)

Returns from Anixa Biosciences Stock

₹7,121 (-7.12%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Anixa Biosciences Stock

-47%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Anixa Biosciences Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Anixa Biosciences, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
4.32%
Laird Norton Tyee Trust Co
1.92%
Davidson D A & Co
1.91%
UBS Group AG
1.63%
Mission Wealth Management, LLC
1.15%
Geode Capital Management, LLC
1.06%

Analyst Recommendation on Anixa Biosciences Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Anixa Biosciences(by analysts ranked 0 to 5 stars)

Anixa Biosciences Share Price Target

What analysts predicted

Upside of 200.0%

Target:

$9.00

Current:

$3.00

Anixa Biosciences share price target is $9.00, a slight Upside of 200.0% compared to current price of $3.00 as per analysts' prediction.

Anixa Biosciences Stock Insights

Price Movement
In the last 7 days, ANIX stock has moved down by -2.3%
ANIX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 80.4%
ANIX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 144.3%

Anixa Biosciences Technicals Summary

Sell

Neutral

Buy

Anixa Biosciences is currently in a neutral trading position according to technical analysis indicators.

Anixa Biosciences, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Anixa Biosciences, Inc.	-0.66%	5.28%	-7.43%	-30.47%	54.92%
Regeneron Pharmaceuticals, Inc.	3.92%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-15.42%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	11.08%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Anixa Biosciences, Inc.	NA	NA	NA	-0.38	-0.65	-0.4	NA	0.5
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Anixa Biosciences, Inc.	Buy	$96.3M	54.92%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the most lethal form of breast cancer; and the development of a vaccine against ovarian cancer, as well as a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Organization	Anixa Biosciences
Employees	5
CEO	Dr. Amit Kumar Ph.D.
Industry	Electronic Technology

Key Management of Anixa Biosciences, Inc.

Name	Title
Dr. Amit Kumar Ph.D.	CEO, Chairman & Co-Chair of CBAB
Mr. Michael J. Catelani CPA, MBA	President, COO, CFO & Corporate Secretary
Dr. Pamela D. Garzone Ph.D.	Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Important FAQs about investing in ANIX Stock from India :

What is Anixa Biosciences share price today?

Anixa Biosciences share price today is $3.00 as on August 30, 2025 at 1:29 am IST at the close of the market. Anixa Biosciences share today touched a day high of $3.01 and a low of $2.99.

What is the 52 week high and 52 week low for Anixa Biosciences share?

Anixa Biosciences share touched a 52 week high of $4.20 and a 52 week low of $2.07. Anixa Biosciences stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.00, lower by 28.57% versus the 52 week high.

How to invest in Anixa Biosciences Stock (ANIX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anixa Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anixa Biosciences Shares that will get you 0.5000 shares as per Anixa Biosciences share price of $3.00 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Anixa Biosciences Stock (ANIX) from India?

Indian investors can start investing in Anixa Biosciences (ANIX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Anixa Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Anixa Biosciences share’s latest price of $3.00 as on August 30, 2025 at 1:29 am IST, you will get 3.3333 shares of Anixa Biosciences. Learn more about fractional shares .

What are the returns that Anixa Biosciences has given to Indian investors in the last 5 years?

Anixa Biosciences stock has given 54.92% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?